StrokeViewer Perfusion
Overview
StrokeViewer Perfusion, developed by NICo-Lab B.V., is an advanced AI-powered image processing software application designed to revolutionize acute stroke care. Integrated within the broader StrokeViewer platform, it analyzes CT perfusion (CTP) images of the brain to provide quantitative perfusion information for suspected ischemic stroke patients.
The tool generates intuitive and easy-to-read perfusion maps, including TMax (Time to Maximum Contrast Enhancement), CBF (Cerebral Blood Flow), CBV (Cerebral Blood Volume), and Lesion Maps, which identify and quantify core and penumbra volumes. This critical information aids clinicians in evaluating brain tissue viability and making informed decisions about treatment eligibility, particularly for late-window stroke patients who may benefit from thrombectomy.
Beyond perfusion analysis, StrokeViewer offers a comprehensive suite of tools for the entire stroke workflow, including Large Vessel Occlusion (LVO) detection, hemorrhage detection and quantification, collateral assessment, and ASPECT scoring. It supports rapid triaging of stroke patients by automatically analyzing images and sending mobile notifications to stroke teams, enabling quick review and collaboration from any device.
Built on a cloud-native architecture, StrokeViewer Perfusion ensures easy implementation in any hospital without requiring additional hardware, and it integrates with standard reading environments like PACS. The platform is designed to accelerate time to treatment, improve patient outcomes, and facilitate seamless communication within stroke networks.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered CT Perfusion analysis
- Quantitative perfusion maps (TMax, CBF, CBV)
- Lesion map for core and penumbra volume quantification
- Large Vessel Occlusion (LVO) detection
- Hemorrhage detection and quantification
- Collateral circulation assessment
- ASPECTS scoring
- Mobile notifications for critical findings
- Remote image review via web-based DICOM viewer
- Secure chat and screen sharing for team collaboration
- Cloud-native architecture for easy deployment
- Integration with PACS and standard reading environments
Use Cases
- Rapid diagnosis of acute ischemic stroke
- Determining treatment eligibility for stroke patients
- Facilitating inter-hospital communication and patient transfers
- Remote consultation and diagnosis by stroke specialists
- Optimizing stroke workflow and reducing time to treatment
- Assessing brain tissue viability for thrombectomy decisions
What Physicians Need to Know
Leverage StrokeViewer Perfusion for rapid, quantitative assessment of ischemic core and penumbra, especially in the 6-24 hour window, to guide thrombectomy decisions. Always interpret AI results in conjunction with the full clinical picture and original imaging data, utilizing the transparent display of underlying perfusion maps and thresholds to validate findings. The mobile access and communication features are crucial for accelerating decision-making and inter-hospital collaboration in time-critical stroke care. Be aware that while notifications are instant, specific alert fatigue management features are not detailed, so integrate thoughtfully into existing alert protocols.
StrokeViewer is a cloud-based solution that integrates with PACS and offers a web-based DICOM viewer for flexible access. Its design supports seamless communication and image sharing across stroke networks, including hub-and-spoke models, facilitating rapid patient triage and transfer. The platform is also noted to partner with companies like Philips to integrate into broader stroke care pathways.
Details
| Category | Neurology AI, Radiology & Imaging AI |
| Pricing | Contact for pricing — N/A |
| Deployment | Cloud-based; can be installed as a Docker container on standard computers or virtual platforms. |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated StrokeViewer Perfusion received 510(k) clearance (K231570) from the U.S. Food and Drug Administration (FDA) on December 14, 2023, for image processing and analysis of CT perfusion images of the brain to provide quantitative perfusion information in brain tissue for suspected ischemic stroke patients. This clearance expands NICo-Lab's comprehensive portfolio of FDA-cleared AI-powered imaging tools for stroke care. |
| Integrations | |
| EHR | Not specified |
| Specialties | Emergency Medicine, Neurology, Radiology |
What the Web Says
StrokeViewer Perfusion, developed by Nicolab, is a medical imaging software designed to aid in the diagnosis and treatment planning for stroke patients by providing rapid and automated analysis of perfusion CT scans. It aims to streamline workflows and improve decision-making in acute stroke care. Reviews highlight its speed and integration capabilities as key benefits.
Overall: PositiveStrengths
- Rapid and automated analysis of perfusion CT scans
- Aids in faster decision-making for stroke treatment
- Streamlines workflow in acute stroke settings
- User-friendly interface (reported by some users)
- Good integration with existing PACS systems
- Potential to improve patient outcomes through quicker intervention
Limitations
- Cost can be a barrier for smaller institutions
- Requires specific hardware/software compatibility
- Learning curve for new users, though generally considered manageable
- Reliance on accurate initial scan quality
- Limited detailed public reviews from a wide range of sources
- Some users desire more customization options
Based on reviews from: Nicolab Website (product information), Medical Technology Review Articles (general), Healthcare IT Forums (general discussions), Physician Forums (anecdotal mentions), G2 (limited specific reviews), Capterra (limited specific reviews)
Last updated: 2026-07-18
Ratings & Reviews
Rate StrokeViewer Perfusion
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for StrokeViewer Perfusion.
Frequently Asked Questions
Compare StrokeViewer Perfusion
VS
VS
VS
VS





